Biotech · Private company

D3 Bio (Wuxi) Co., Ltd

Track this companyFree. Adds D3 Bio (Wuxi) Co., Ltd to your Dealase workspace and tells you when its record changes.

Clinical trials44 recruiting or active

Pipeline programs10From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline10

A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation.PHASE1 · RECRUITING · started May 29, 2026ClinicalTrials.gov NCT07456046 · fetched Nov 12, 2026
A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid TumorsPHASE1 · RECRUITING · started Sep 19, 2023ClinicalTrials.gov NCT05957536 · fetched Nov 12, 2026
A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway MutationsPHASE1_PHASE2 · RECRUITING · started Jul 10, 2023ClinicalTrials.gov NCT05886920 · fetched Nov 12, 2026
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C MutationPHASE1_PHASE2 · RECRUITING · started Aug 3, 2022ClinicalTrials.gov NCT05410145 · fetched Nov 12, 2026